Previous Article | Next Article ![]()
Journal of Bacteriology, April 2002, p. 1905-1915, Vol. 184, No. 7
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.7.1905-1915.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Microbiology and Plant Molecular Biology/Biotechnology Program, The Ohio State University, Columbus, Ohio 43210-1292
Received 26 September 2001/ Accepted 9 January 2002
|
|
|---|
|
|
|---|
Enzymes of the CBB pathway are encoded by the cbb genes, which are organized in regulons in both Rhodobacter capsulatus (44, 45) and Rhodobacter sphaeroides (19, 23, 24). For both organisms, there are two major cbb operons: the form I (cbbI) operon, containing form I RubisCO genes (cbbL cbbS), is predominant under autotrophic growth conditions, and the form II (cbbII) operon, containing the form II RubisCO gene (cbbM), is expressed under all growth conditions, albeit at enhanced levels during autotrophic growth. In R. sphaeroides, a LysR-type transcriptional activator gene (cbbR) is situated upstream and is divergently transcribed from the cbbI operon, with CbbR activating expression of both cbbI and cbbII promoters (21). By contrast, R. capsulatus contains a separate cbbR gene upstream and divergently transcribed from each cbb operon (44, 45), with each operon being independently regulated by its cognate CbbR activator (46, 67). CbbR has also been identified and in some cases shown to control cbb expression in many other autotrophic organisms that employ the CBB pathway. These organisms include Rhodospirillum rubrum (16), Thiobacillus ferrooxidans (34), Xanthobacter flavus (39), Ralstonia eutropha (Alcaligenes eutrophus) (71), Chromatium vinosum (65), and Nitrobacter vulgaris (56). LysR-type transcriptional regulators generally utilize a metabolite or coinducer produced by the pathway they regulate (52). The nature of the signal(s) for CbbR has remained unclear, although some "organism-dependent specificity in the coinducer" has been suggested (59). For example, NADPH enhances the binding of X. flavus CbbR (64) while exhibiting no effect on CbbR from R. eutropha (26), R. capsulatus (P. Vichivanives and F. R. Tabita, unpublished results), or R. sphaeroides (J. M. Dubbs and F. R. Tabita, unpublished results).
Previous studies with R. capsulatus suggested that a metabolic signal(s) generated by enzymes encoded by the cbbII genes, downstream of cbbP (PRK) but before cbbM (form II RubisCO), might contribute to the regulation of cbb expression in response to photoheterotrophic and photoautotrophic growth conditions (46, 62). For example, the RubisCO (cbbLS cbbM)-deficient strain SBI/II maximally expressed cbb promoter activities during photoheterotrophic growth which favor activation of the dimethylsulfoxide reductase (DMSOR) system, while a PRK (cbbP)-deficient strain exhibited wild-type control (62). SBI/II thus presented a useful tool to examine the nature of the metabolic signal(s) that could influence CbbR-mediated cbb expression. This work presents in vivo studies that suggest that a product generated by PRK contributes to CbbR-mediated control of cbb expression in an R. capsulatus SBI/II background.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Relevant characteristics of bacterial strains and plasmids used in this study
|
![]() View larger version (17K): [in a new window] |
FIG. 1. cbbI and cbbII gene clusters of R. capsulatus. The sites of gene disruptions in the mutant strains are indicated. Solid arrows indicate direction of transcription; dotted arrows indicate orientation of the gentamicin resistance cassette used to inactivate the respective genes. The genes encoding the enzymes of the CBB pathway in R. capsulatus are organized in two operons, each preceded by a separate cbbR gene (encoding a LysR-type transcriptional regulator). cbbL cbbS encodes form I RubisCO, while cbbM encodes form II RubisCO. cbbM is clustered with genes encoding other enzymes of the CBB pathway: cbbF (fructose 1,6/sedoheptulose 1,7-bisphosphatase), cbbP (phosphoribulokinase), cbbT (transketolase), cbbG (glyceraldehydes-3-phosphate dehydrogenase), cbbA (fructose 1,6-bisphosphate aldolase), and cbbE (epimerase). The cbb genes are oriented with respect to other familiar genes in this organism: pgm, phosphoglucomutase; qor, quinol oxidoreductase; anfA, regulator for the alternative nitrogenase genes.
|
Cell extracts and enzyme assays. Culture samples (10 to 30 ml) were harvested in late log phase (optical density at 660 nm, 0.9 to 1.2), washed in buffer (25 mM Tris-HCl, 1 mM EDTA [pH 8.0]), and disrupted by sonication. The resultant cell debris was removed by centrifugation for 15 min at 4°C. ß-Galactosidase activity was measured as previously reported (46); the production of o-nitrophenol (40) was continuously measured by monitoring the increase in absorbance at 405 nm over 10 min. RubisCO activity was assayed as previously described by measuring RuBP-dependent 14CO2 fixation into acid-stable material (70). PRK activity was measured by previously described protocols (57) except that ribulose 5-phosphate was generated from ribose 5-phosphate by the addition of 5 U of phosphoriboisomerase (Sigma Chemical, St. Louis, Mo.). The following CBB enzymatic activities were measured spectrophotometrically on a Beckman DU-70 spectrophotometer by using a coupled enzyme assay following established protocols: fructose 1,6-bisphosphatase (FBPase) (20), transketolase (60), and ribulose 5-phosphate-3-epimerase (35). Protein concentrations were determined with a protein assay dye binding reagent (Bio-Rad Laboratories, Hercules, Calif.) with bovine serum albumin as a standard.
Western immunoblot analysis of form I and form II RubisCO. Samples were prepared and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis as previously described (36). A low cross-linker ratio (acrylamide to bisacrylamide, 150/1) was utilized in 18% polyacrylamide gels. Following electrophoresis, proteins were transferred to polyvinylidene difluoride membranes (Immobilon-NC; Millipore, Bedford, Mass.) (63) using a Bio-Rad Transblot semidry cell. Polyclonal antibodies raised against Synechococcus sp. PCC 6301 RubisCO and R. sphaeroides form II RubisCO at a 1:3,000 dilution were utilized to follow the synthesis of form I and form II RubisCO, respectively. Western blots were developed by following protocols of the Vistra ECF fluorescent detection system (Amersham Corporation, Little Chalfont, Buckinghamshire, England). Blots were visualized with a Storm 840 imaging system (Molecular Dynamics, Sunnyvale, Calif.).
DNA manipulations and conjugation techniques.
All routine DNA manipulations were carried out following standard protocols (1). R. capsulatus chromosomal DNA was isolated as previously described (25). Southern blotting procedures were carried out with Hybond N+ (Amersham, Arlington Heights, Ill.) membranes following previously established protocols supplied with GeneScreen Plus membranes (NEN, Dupont, Boston, Mass.). Hybridizations, labeling of probes, and development of blots were conducted by following protocols of the Vistra ECF fluorescent detection system (Amersham Corporation). Blots were visualized with a Storm 840 imaging system. For complementation experiments, E. coli strain JM107 (73) containing the mobilizable helper plasmid pRK2013 (18) was used in triparental matings. To generate mutant strains, derivatives of plasmid pJP5603 were conjugated into R. capsulatus strain SBI/II or SBI using E. coli S17-
pir (11, 47).
Construction of R. capsulatus mutant strains by insertional mutagenesis. (i) Strain SBI/IIP (cbbLS cbbM cbbP).
cbbP was inactivated by insertion of a gentamicin resistance cassette as a 1.56-kb SalI fragment isolated from plasmid pUC1318-Gm into the unique XhoI site of cbbP in plasmid pK18FIIB2.3, generating plasmid pK18-cbbPGm. The 3.8-kb KpnI-XbaI fragment of pK18-cbbPGm, containing the disrupted cbbP gene, was cloned into the suicide vector pTC5603, generating plasmid pTC5603-cbbPGm. pTC5603-cbbPGm was mobilized into R. capsulatus strain SBI/II from E. coli strain S17-
pir. Of the 1,350 Gmr exconjugants screened, 4 were found to be Tets. Southern blot analysis of chromosomal DNA indicated that each of the Gmr Tets isolates resulted from double recombination.
(ii) Strain SBI/IIT (cbbLS cbbM cbbT).
In order to isolate a unique XhoI site in the cbbT gene, a 2.0-kb BamHI fragment containing a truncated cbbT gene was subcloned from plasmid pK18FIIS4 into plasmid pUC19, generating plasmid p19-cbbT'. Inactivation of cbbT was achieved by insertion of a gentamicin resistance cassette as a 1.56-kb SalI fragment isolated from pUC1318-Gm into the XhoI site of cbbT in p19-cbbT', generating p19-cbbTGm. A cointegrate of p19-cbbTGm and the suicide plasmid pJPTC was formed after linearizing the DNA with EcoRI, resulting in plasmid pJPTC-cbbTGm. E. coli strain S17-
pir was used to mobilize pJPTC-cbbTGm into R. capsulatus strain SBI/II. Of the 700 Gmr exconjugants screened, 1 was found to be Tets and confirmed to be a double crossover by Southern blot analysis of chromosomal DNA.
(iii) Strain SBI/IIRII (cbbLS cbbM cbbRII).
Inactivation of cbbRII was accomplished by insertion of a gentamicin resistance cassette as a 1.56-kb SmaI fragment from plasmid pUC1318-Gm into the unique EcoRV site of cbbRII in plasmid pK18FIIS4.4, generating plasmid pK18-cbbRGm. pJPTC-cbbRGm was generated by forming a cointegrate between pK18-cbbRGm and the suicide vector pJPTC, after linearizing the DNA with EcoRI. pJPTC-cbbRGm was mobilized into R. capsulatus strain SBI/II by using E. coli strain S17-
pir. Of the 500 Gmr exconjugants, 162 were found to be Tets; 8 were chosen for Southern blot analysis of chromosomal DNA, and all were confirmed to be double crossovers. One of these strains was chosen for all subsequent experiments.
(iv) Strain SBI/P (cbbLS cbbP).
Inactivation of cbbP was achieved by mobilizing plasmid pTC5603-cbbPGm from E. coli strain S17-
pir into R. capsulatus strain SBI. Of the 4,100 Gmr exconjugants screened, 1 was found to be Tets. Southern blot analysis of chromosomal DNA indicated that the Gmr Tets isolate resulted from double recombination.
|
|
|---|
![]() View larger version (27K): [in a new window] |
FIG. 2. Immunoblot analysis and levels of RubisCO and PRK activities in strain SBI/P during photoheterotrophic growth. Antibodies raised against form I Synechococcus 6301 RubisCO (A) and R. sphaeroides form II RubisCO (B) were utilized. Approximately 5 µg of protein was added per lane (A and B). Levels of RubisCO activity (below the lanes) and PRK activity (below the lanes, in parentheses) (both in nanomoles per minute per milligram) were determined from three independent cultures grown photoautotrophically (1.5%CO2-98.5% H2) (lane 1) or photoheterotrophically in the presence of DMSO (lanes 3 to 5). Lanes 1, extract from wild-type strain SB1003; lanes 2, purified Synechococcus sp. strain 6301 RubisCO (A) and R. sphaeroides form II RubisCO (B); lanes 3, extract from SB1003; lanes 4, extract from SBI; lanes 5, extract from SBI/P. ND, not determined.
|
Metabolic control of the CBB pathway in R. capsulatus. Previous physiological studies suggested that a metabolic signal produced by enzymes encoded by the R. capsulatus cbbII genes, in particular the product of a gene downstream of cbbP, but before cbbM (form II RubisCO), contributes to regulation of the CBB pathway (46, 62). To address this issue, insertional mutagenesis was performed on strain SBI/II, whereby specific genes (see orientation in Fig. 1) encoding PRK (cbbP), transketolase (cbbT), and the LysR-type transcriptional activator CbbRII (cbbRII) were inactivated (see Materials and Methods).
Form I RubisCO is not synthesized under photoheterotrophic growth conditions when malate is used as the carbon source in wild-type R. capsulatus (19, 45, 55). Accordingly, wild-type strain SB1003 exhibited no cbbI promoter activity for all photoheterotrophic growth conditions examined. Strain SBI/II exhibited cbbI promoter activity during photoheterotrophic growth and levels were substantially enhanced during growth with DMSO (Fig. 3A) as previously reported (62). Indeed, promoter activities in SBI/II approached the levels obtained in the wild type under photoautotrophic growth conditions, which is known to be a growth condition that favors maximum cbb transcription (46, 61, 62). However, when a knockout mutation in the cbbP gene was constructed in this strain (creating strain SBI/IIP), as observed in the wild type, no cbbI promoter activity was noted for all photoheterotrophic growth conditions (Fig. 3A). Strain SBI/IIRII exhibited levels of cbbI promoter activity approximately fourfold lower than those of strain SBI/II for malate-ammonia-DMSO and malate-glutamate growth conditions and no promoter activity for growth with malate-glutamate-DMSO (Fig. 3A). Compared to strain SBI/II, strain SBI/IIT also exhibited high levels of cbbI promoter activity during growth with malate-ammonia-DMSO. By contrast, however, levels were greatly enhanced compared to wild-type levels during growth in the absence of DMSO (malate-glutamate) and decreased 4.8-fold during malate-glutamate-DMSO growth (Fig. 3A). For cbbII promoter activity, for all photoheterotrophic growth conditions tested, activity was readily detected in wild-type strain SB1003. However, SBI/II exhibited a 13- to 14-fold induction of cbbII promoter activity when cultures were supplemented with DMSO (Fig. 3B) (62). Like the cbbI promoter results, SBI/IIP regained wild-type control of its cbbII promoter activity during photoheterotrophic growth, although slightly less activity was observed with malate-glutamate-DMSO than for the wild-type (Fig. 3B). These results were similar to what occurred in PRK deletion strains of wild-type R. capsulatus (62). SBI/IIT enhanced cbbII promoter activity to levels comparable to those for SBI/II under photoheterotrophic growth conditions when cultures were supplemented with DMSO. However, for this strain, enhanced levels of promoter activity were obtained in cultures grown in the absence of DMSO (malate-glutamate) (Fig. 3B). Levels of cbbII promoter activity in strain SBI/IIRII were considerably reduced for all the photoheterotrophic growth conditions tested (Fig. 3B) and were at levels observed with R. capsulatus cbbRII strains (46, 67).
![]() View larger version (32K): [in a new window] |
FIG. 3. cbbI::lacZ (A) and cbbII::lacZ (B) promoter activity during photoheterotrophic growth of R. capsulatus strains. ß-Galactosidase activities were determined from three to nine independent cultures assayed in duplicate. NG, no growth during photoheterotrophic conditions with ammonia as the nitrogen source in the absence of DMSO.
|
|
View this table: [in a new window] |
TABLE 2. CBB enzymatic activities during photoheterotrophic growth with ammonia and DMSO
|
), containing the respective cbb gene(s), was mated into SBI/IIP, levels of FBPase activity were not significantly altered during photoheterotrophic growth with DMSO (Table 2). SBI/II, containing pRPSFIIS2-1, with the cbbM gene from R. capsulatus (encoding form II RubisCO), possessed decreased levels of PRK and transketolase activity, to near wild-type levels; moreover, levels of FBPase activity decreased significantly (Table 2). These results indicated that the restoration of a functional CBB pathway in SBI/II (pRPSFIIS2-1) (containing R. capsulatus form II RubisCO) diminished the accumulation of some important metabolite that influenced regulation when RubisCO activity was blocked. This putative compound would appear to substantially contribute to up-regulated gene expression in SBI/II during photoheterotrophic growth with DMSO (62). R. capsulatus SBII, which has no form II RubisCO, had been shown to synthesize form I RubisCO during photoheterotrophic growth, unlike wild-type strains (46). Thus, in order to compensate for the absence of form II RubisCO, a signal is processed to somehow allow SBII to synthesize compensatory levels of form I RubisCO. Consistent with these observations, cbbI promoter activity became detectable in SBII after photoheterotrophic growth with ammonia (Table 3). This cbbI promoter activity was observed under photoheterotrophic growth conditions with either ammonia or glutamate as the nitrogen source in the absence or presence of DMSO. Wild-type strain SB1003, as previously shown (62), exhibited no cbbI promoter activity (Table 3). SBII enhanced levels of cbbII promoter activity 7.2-fold compared to SB1003 during malate-ammonia growth, while levels were enhanced 3.4-fold during malate-ammonia-DMSO growth and 2.4- to 2.5-fold during malate-glutamate growth regardless of the presence of DMSO (Table 3). SBII also showed enhanced levels of PRK activity (2.5- to 2.6-fold) compared to SB1003 during photoheterotrophic growth in the presence or absence of DMSO (data not shown). Similar to the situation with SBI/II (Table 2), upon the restoration of a complete CBB pathway via complementation with the R. capsulatus cbbM gene (encoding form II RubisCO) using plasmid pRPS::FII(S2)-I, decreased levels of PRK activity were obtained (data not shown).
|
View this table: [in a new window] |
TABLE 3. Levels of cbbI and cbbII promoter activities in strain SBII during photoheterotrophic growth
|
![]() View larger version (28K): [in a new window] |
FIG. 4. Promoter activity using an R. sphaeroides cbbR-cbbI::lacZ promoter fusion (pVKD1) (9) in R. capsulatus strains during photoheterotrophic growth. ß-Galactosidase activities were determined from three independent cultures assayed in duplicate. NG, no growth in the absence of an alternative electron acceptor.
|
|
View this table: [in a new window] |
TABLE 4. Complementation of R. capsulatus strain SBI/IIRII during photoheterotrophic growth with DMSO (malate-ammonia-DMSO)
|
|
|
|---|
LysR-type transcriptional activators generally require a coinducer, and this effector ligand is often a metabolite of the pathway regulated (52). With respect to the cbb operons of R. capsulatus, previous studies have shown that these operons belong to independent CbbR regulons (44, 46, 67). It has also been suggested that under phototrophic growth conditions, different inducer molecules could bind to the respective CbbR proteins or, alternatively, that CbbRI and CbbRII could bind the same inducer molecule but with different affinities (46). The present investigation strongly indicated a potential regulatory role of a metabolite generated by PRK function (either ADP, RuBP, or a derivative thereof). Presumably, this compound might act as a specific effector in mediating the ability of CbbRI and CbbRII to influence control of cbb expression in SBI/II. Previous physiological studies (46, 62) and genetic studies reported here have thus stimulated us to direct attention to the ability of such metabolites to influence CbbR function in vitro. It is clear, however, from the present studies that the enhanced levels of cbbII promoter activity in SBI/II were dependent on CbbRII, since inactivation of the cbbRII gene in SBI/II resulted in decreased basal levels of cbbII expression. Levels of PRK activity in SBI/IIRII were approximately 4% of wild-type levels during photoheterotrophic growth in the presence of DMSO (Table 2). Perhaps, the lower levels of PRK activity in SBI/IIRII contributed to the approximate fourfold reduction of cbbI promoter activity in this strain during photoheterotrophic growth. It is also apparent from mutagenesis studies presented here and elsewhere (62) that a separate metabolic signal (besides RuBP, ADP, or a derivative thereof) might be involved in the control of cbbII expression during photoheterotrophic growth, since SBI/IIP exhibited wild-type control of cbbII expression (Fig. 3B); additionally, cbbP strains generated by a polar mutation exhibited wild-type control of cbbII promoter activity during photoheterotrophic growth (62). Obviously, there exists an alternative signal that must be involved in CbbRII-mediated regulation of cbbII expression during photoheterotrophic growth. Presumably, this hypothetical signal is generated via processes separate from the function of structural genes downstream of and including cbbP. Again, if one assumes that the regulatory compound is generated by the CBB pathway, a potential metabolite candidate could possibly be the product generated by CbbF (fructose 1,6-bisphosphatase), namely, fructose 6-phosphate, since the cbbF gene is upstream of cbbP and is not inactivated by the polar effect of a cbbP mutation. Additional work obviously needs to be completed to reinforce these hypotheses. Certainly, the ability of LysR-type transcriptional activators to bind two separate inducer molecules is not unprecedented. For example, BenM, a LysR-type transcriptional activator involved in the regulation of benzoate degradation in Acinetobacter sp. strain ADP1, has been shown to utilize two compounds of the pathway, benzoate and cis,cis-muconate, as effector molecules (6).
It is clear that both cbb operons are independently regulated in R. capsulatus 46, 62; this study) and R. sphaeroides (24, 27, 28). The present study shows that cbbI and cbbII promoter activities of R. capsulatus are both substantially enhanced during photoheterotrophic growth in the presence of DMSO in the RubisCO-deficient strain SBI/II. Indeed, the enhanced levels observed reached those obtained by the wild-type during photoautotrophic (1.5% CO2-98.5% H2) growth (62). It is thus apparent that a signal was generated in SBI/II that led to the deregulation and control of cbbI and cbbII expression under photoheterotrophic growth conditions in the presence of DMSO. Furthermore, this enhanced cbbI and cbbII promoter activity was lost when cbbP was inactivated (Fig. 3 and Table 2), causing a regain of the wild-type pattern of control. Consequently, we hypothesize that a metabolic signal generated by PRK function (ADP, RuBP, or a metabolite derived from RuBP) serves as a positive effector to enable CbbRI and CbbRII to enhance cbb gene expression in SBI/II. Such an effector also provides a common metabolic signal for communication between the two operons. Because effector compounds for LysR type regulators are usually metabolites unique to the pathway, we suggest that RuBP, or something directly derived from RuBP, is the most likely candidate for the coinducer or effector. The coincidence of the levels of cbb expression with levels of PRK function in SBI/II is certainly supportive of this idea. Moreover, upon restoration of a functional CBB pathway (by complementation with the R. capsulatus form II RubisCO gene), levels of PRK activity decreased 6.1-fold, which presumably diminished the intracellular levels of a metabolite that accumulated when RubisCO activity was blocked; this could contribute to the 3.1-fold decrease in FBPase activity and the 3.3-fold decrease in transketolase activity exhibited by SBI/II containing a functional form II RubisCO (Table 2). Additionally, levels of PRK activity appeared to be coincident with cbb induction in response to a photoautotrophic growth environment (1.5% CO2-98.5% H2) in SBI/II containing form II RubisCO (data not shown). From these findings, it appears that PRK function, and the levels of RuBP (or a metabolite derived from RuBP), appeared to contribute to CbbR-mediated cbbI and cbbII expression in SBI/II.
Further communication between the two cbb operons is illustrated by R. capsulatus SBII; unlike the wild type, SBII synthesized form I RubisCO under photoheterotrophic growth conditions with malate as the carbon source (46). This compensatory increase in the expression of the cbbI operon in SBII was reflected by enhanced levels of cbbI promoter activity, compared to the wild type, during photoheterotrophic growth with either ammonia or glutamate as the nitrogen source in the absence or presence of DMSO (Table 3). Somehow a signal was received in SBII to allow the organism to compensate for the absence of form II RubisCO. This compensation resulted in the synthesis of form I RubisCO under conditions where the cbbI operon was normally not functional. It should be noted, however, that no signal for compensatory form I RubisCO synthesis was evident in various cbbP mutant strains, where a polar effect on cbbM also causes form II RubisCO not to be synthesized (46, 62). SBII also exhibited enhanced levels of cbbII promoter and enhanced PRK activity levels compared to the wild type under photoheterotrophic growth conditions (Table 3; also data not shown). Again, it is tempting to speculate that a signal for the compensatory effect on cbbI expression in SBII is, in part, mediated by enhanced levels of a metabolite generated by PRK function during photoheterotrophic conditions, as is the case for SBI/II. In R. sphaeroides, the intracellular level of RuBP or a metabolite derived from RuBP also appears to be important for cbb expression control. Thus, similar to R. capsulatus, when cbbM was disrupted by a polar mutation in cbbAII, levels of PRK activity were enhanced over wild-type levels during photoheterotrophic growth in R. sphaeroides (27; D. L. Falcone, J. L. Gibson, and F. R. Tabita, unpublished data). Finally, recent experiments performed by S. A. Smith in this laboratory indicated that enhanced levels of cbbI and cbbII promoter activities were manifest in an R. sphaeroides RubisCO deficient strain during photoheterotrophic growth in the presence of DMSO (malate-ammonia-DMSO) (S. A. Smith and F. R. Tabita, unpublished observations). Since we have shown that R. sphaeroides cbbI promoter activity was up-regulated and dependent on R. sphaeroides CbbR in an R. capsulatus SBI/IIRII background, similar to R. capsulatus cbbI, there appears to be a common and important role for the product of PRK in both organisms. The different abilities of R. sphaeroides CbbR, R. capsulatus CbbRI or CbbRII, and Rhodospirillum rubrum CbbR to complement R. capsulatus SBI/IIRII might reflect differences in the specificity of the coinducer(s) used, the nature of the DNA binding motifs, or affinities for binding motifs or might even reflect the requirement for specific interactions with additional factors. Obviously additional studies need to be performed in order to resolve these multiple possibilities; however, preliminary in vitro studies indicate that RuBP might have differential capabilities to influence the binding of CbbRI and CbbRII to its cognate promoter sites (66).
Finally, there are both known and unknown additional regulatory components and factors that are involved in controlling expression of the CBB system (9, 10, 67). For example, there is the RegB/A(PrrB/A) two-component signal transduction system, originally shown to control transcription of key operons involved in photosystem biosynthesis in R. capsulatus (30, 41), R. sphaeroides (13), and probably other nonsulfur purple photosynthetic bacteria (38) via a mechanism that shows organism-dependent specificity (3, 13, 14, 41, 54). More recently, RegB/A(PrrB/A) was found to function as a global two-component regulatory system (31), as it controls, among other processes, CO2 fixation in R. capsulatus (67) and R. sphaeroides (10, 50), nitrogen fixation in R. capsulatus (12, 61), R. sphaeroides (31, 51), Rhodospirillum rubrum (31), and Bradyrhizobium japonicum (4), H2 oxidation in R. capsulatus (12), and the regulation of formaldehyde oxidation in R. sphaeroides (2). With regard to the cbb system of R. capsulatus, Reg/Prr is involved in activation of cbbI promoter expression as well as maximal expression of the cbbII promoter under photoautotrophic growth conditions (67). It was further suggested that alteration of the oxidation-reduction potential of the ubiquinone pool, by activation of the DMSOR system, enables a redox signal to be transmitted to the Reg/Prr system, which in turn regulates the expression of key operons involved in phototrophic metabolism, including the cbb regulons of R. capsulatus (62). Perhaps, the enhanced levels of cbb expression observed during photoheterotrophic growth with DMSO in SBI/II is a result of the cooperative regulation by both the LysR-type regulatory activators CbbRI and CbbRII and the global response regulator RegA. It is thus conceivable that a synergistic interaction between CbbR and RegA occurs at the respective cbbI and cbbII promoters in SBI/II; the binding of RuBP (or a derivative thereof) to CbbRI and CbbRII could then somehow enhance the effects of RegA control at these promoters. Synergistic control of gene expression by a response regulator of a two-component regulatory system and a LysR-type transcriptional regulator is certainly not unprecedented and has been shown, for example, to be important for control of the eps operon of Ralstonia solanacearum (29). Ultimately, further in vitro studies will need to be performed to address these and other possibilities.
This work was supported by NIH grant GM45404 from the U.S. Public Health Service.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»